Fundraising Fox

IO Biotech

9 known investors

IOBiotech appears to be a biotech company focused on oncology, with a founder who has extensive experience in cancer drug development and clinical advancement from roles at Roche, Eli Lilly, and leading academic cancer centers.

BiotechMedical Devices

Founders & leadership

DD
Dr. Dhingra

Investors · 9

Avoro Capital AdvisorsNew York
EIR VenturesStockholm
Kurma PartnersParis · $162K – $10.8M
RA CapitalBoston
Samsara BioCapitalPalo Alto
Sunstone CapitalFrederiksberg
Vivo CapitalPalo Alto · $10M – $50M
European Investment Bankreported · 2 sourcesLuxembourg
HBM Healthcare InvestmentsreportedZug

In the news

The rollercoaster ride stopps and danish IO Biotech goes bust - European Biotechnology Magazineeuropean-biotechnology.com · Apr 2026IO Biotech secures up to €57.5 million in debt financing from the European Investment Bankglobenewswire.com · Dec 2024Avoro Capital Advisors | Newsavorocapital.com · Jun 2021IO Biotech Completes Oversubscribed EUR 127 Million Series B Financing to Accelerate Clinical Programs in Oncologyprnewswire.com · Jan 2021IO Biotech raises $155M to trial IDO and PD-L1 cancer vaccines | Fierce Biotechfiercebiotech.com · Jan 2021IO Biotech Announces 2023 Fourth-Quarter and Year-End Resultsstreetinsider.com

Frequently asked questions

What does IO Biotech do?
IOBiotech appears to be a biotech company focused on oncology, with a founder who has extensive experience in cancer drug development and clinical advancement from roles at Roche, Eli Lilly, and leading academic cancer centers.
Who are IO Biotech's investors?
IO Biotech's investors include Avoro Capital Advisors, EIR Ventures, Kurma Partners, RA Capital, Samsara BioCapital, Sunstone Capital, Vivo Capital, European Investment Bank and 1 more.